How many insider declarations has Canaan XI L.P. filed?

Canaan XI L.P. has filed 11 public insider declarations with SEC (Form 4).

What is Canaan XI L.P.'s role?

Canaan XI L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Canaan XI L.P. report trades for?

Canaan XI L.P. reports trades for 2 companies, including Day One Biopharmaceuticals, Inc..

What is Canaan XI L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 16.0M€.

← Executives ★ Sign in to follow

CX

Canaan XI L.P.

Other

US·SEC (Form 4)

Day One Biopharmaceuticals, Inc.Tyra Biosciences, Inc.

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€16m

▼ Sales (3 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

3

T+90 hit rate

25%

T+90 mean return

-11.6%

Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the complete record of transactions filed by Canaan XI L.P.. Director active across 2 companies, notably Day One Biopharmaceuticals, Inc.. In total, 11 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €16m. History available since 13 September 2022. The latest transaction was disclosed on 21 September 2022 (Cession). Regulator: SEC (Form 4). The full history is free.

Declarations11 total

▼

Canaan XI L.P.

Executives21 Sept 2022Day One Biopharmaceuticals, Inc.

$11M27SEC ↗

607,497 shares@ US$18.5471.7% of flowCommon StockSEC:0000899243-22-031692:0

▼

Canaan XI L.P.

Executives16 Sept 2022Day One Biopharmaceuticals, Inc.

$2M22SEC ↗

111,585 shares@ US$21.5315.1% of flowCommon StockSEC:0000899243-22-031602:0

▼